Skip to content
Citation only via OpenAlex

Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II–III colon cancer

Ahmet Burak Ağaoğlu, Ferhat Ekinci, Mustafa Şahbazlar, Atike Pınar Erdoğan

Cancer Chemotherapy and Pharmacology · 2026

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1007/s00280-026-04974-x
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Ağaoğlu, A.B., Ekinci, F., Şahbazlar, M., &amp; Erdoğan, A.P. (2026). Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II–III colon cancer. <em>Cancer Chemotherapy and Pharmacology</em>. https://doi.org/10.1007/s00280-026-04974-x
Vancouver
Ağaoğlu AB, Ekinci F, Şahbazlar M, Erdoğan AP. Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II–III colon cancer. Cancer Chemotherapy and Pharmacology. 2026. doi:10.1007/s00280-026-04974-x.
BibTeX
@article{ahmet2026Biolog, title = {Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II–III colon cancer}, author = {Ahmet Burak Ağaoğlu and Ferhat Ekinci and Mustafa Şahbazlar and Atike Pınar Erdoğan}, journal = {Cancer Chemotherapy and Pharmacology}, year = {2026}, doi = {10.1007/s00280-026-04974-x}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings